Federal contract award
75A50119F33009
AS03B-H7N9 VACCINE CLINICAL STUDY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | HHSO100201600004I |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $18.2M |
| Current contract value | $18.2M |
| Potential contract value / ceiling | $18.2M |
| Start date | Aug 28, 2019 |
| Current end date | Apr 29, 2024 |
| Potential end date | Apr 29, 2024 |
| Latest award activity | Sep 9, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 9, 2025 | P00009 | $-1 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE OF GSK?S CONTRACT #HHSO10020160004I TASK ORDER 75A50119F33009; FROM 8/28/2019-2/28/2024 TO 8/28/2019-4/30/2024. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.